U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
“This exercise aims to empower youth by giving them an opportunity to network,” head of the OSCE Office in Yerevan said.
Koppenburg said the study could help differentiate between Standard Model effects and "anything new or unexpected in the future."
The report is designed to shape the debate around new global development goals that are to be finalized next year.
“I think it will be useful if we share the rich experience and the practical skills with the young generation,” Ralph Yirikian said.
Partner news